Browsing by Author "Seijo, Luis"

Sort by: Order: Results:

  • A pilot study on proteomic predictors of mortality in stable COPD
    Enríquez Rodríguez, César Jessé; Casadevall Fusté, Carme; Faner, Rosa; Pascual Guàrdia, Sergi, 1979-; Castro-Acosta, Ady Angélica; López Campos, José Luis; Peces-Barba Romero, Germán; Seijo, Luis; Caguana Vélez, Oswaldo Antonio; Monsó Molas, Eduard; Rodríguez Chiaradia, Diego Agustín; Barreiro Portela, Esther; Cosío, Borja G.; Agustí García-Navarro, Àlvar; Gea Guiral, Joaquim; BIOMEPOC group (MDPI, 2024)
    Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of global mortality. Despite clinical predictors (age, severity, comorbidities, etc.) being established, proteomics offers comprehensive biological ...
  • Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer
    Alcaraz, Jordi; Carrasco, Josep Lluís; Millares, Laura; Luis, Iuliana-Cristiana; Fernández-Porras, Francisco J.; Martínez-Romero, Anabel; Diaz-Valdivia, Natalia; Sánchez de Cos, Julio; Rami-Porta, Ramón; Seijo, Luis; Ramírez, Josep; Pajares, María José; Reguart, Noemí; Barreiro Portela, Esther; Monsó Molas, Eduard (Elsevier, 2019)
    Objectives: Tumor associated fibroblasts (TAFs) are essential contributors of the progression of non-small cell lung cancer (NSCLC). Most lung TAFs exhibit an activated phenotype characterized by the expression of α-SMA ...
  • Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance
    Millares, Laura; Barreiro Portela, Esther; Cortes, Roldan; Martínez-Romero, Anabel; Balcells Nadal, Cristina; Cascante Serratosa, Marta; Enguita, Ana Belen; Álvarez, Carlos; Rami-Porta, Ramón; Sánchez de Cos, Julio; Seijo, Luis; Monsó Molas, Eduard; Grupo Colaborativo en Cáncer de Pulmón CIBERES-CIBERONC-SEPAR-Plataforma Biobanco Pulmonar (Elsevier, 2018)
    INTRODUCTION: Non-small cell lung cancer (NSCLC) patients diagnosed in early stage and surgically-treated have five-year mortality rate >20%. The identification of biomarkers able to predict progression and death may help ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking